Differentiation and characterisation of brain-derived extracellular vesicles fro...
Differentiation and characterisation of brain-derived extracellular vesicles from the peripheral blood for understanding the neuropathophysiological mechanisms of migraine.
Migraine is a major disease burden on society but remains poorly understood. The onset of migraine with aura has been linked to cortical spreading depolarisation (CSD) and Professor Turgay Dalkara (the supervisor) found that induc...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
SAF2017-84773-C2-1-R
TRATAMIENTO Y DIAGNOSTICO DE PATOLOGIAS CEREBROVASCULARES AP...
121K€
Cerrado
PID2020-114885RB-C22
VESICULAS EXTRACELULARES DERIVADAS DEL MICROBIOMA ORAL COMO...
158K€
Cerrado
MindGAP
Bridging the gap between Mind Brain and Body exosome role...
4M€
Cerrado
CROSSTALK
Decoding Extracellular Vesicle-mediated organ crosstalk in v...
2M€
Cerrado
RYC2021-030946-I
Systems biology and clinical proteomics for the study of neu...
236K€
Cerrado
ENSEMBLE
Structure and functions of the brain extracellular space
10M€
Cerrado
Información proyecto DiBDEV
Duración del proyecto: 24 meses
Fecha Inicio: 2022-05-23
Fecha Fin: 2024-06-12
Líder del proyecto
HACETTEPE UNIVERSITESI
No se ha especificado una descripción o un objeto social para esta compañía.
Presupuesto del proyecto
148K€
Descripción del proyecto
Migraine is a major disease burden on society but remains poorly understood. The onset of migraine with aura has been linked to cortical spreading depolarisation (CSD) and Professor Turgay Dalkara (the supervisor) found that inducing CSD in animal models led neurons to release inflammatory proteins in extracellular vesicles (EVs). Because brain-derived (BD)EVs cross the blood-brain barrier and their composition reflects their cellular and temporal origin, they represent biomarkers that, if isolated from the peripheral blood of migraine patients, could give an unparalleled insight into cell-specific neuroinflammation in migraine. However, current methods to isolate cell type-specific BDEVs from the blood insufficiently distinguish them from EVs of other tissues, obscuring crucial insights into cell-specific processes. Here, I (Adam Bennett, the researcher) will develop a workflow to isolate cell type-specific BDEVs from the blood of migraine patients then temporally characterise them to gain a cell-type specific molecular signature during migraine with aura. This will firstly involve the optimisation and validation of isolating neuron, astrocyte and microglia EVs (using a panel of specific markers) from the brains and peripheral blood of rats. Secondly, cell type-specific EVs isolated at different time points post-CSD evocation in rats will be characterised using proteomics to generate temporal cell type-specific data on the pathological processes post-CSD. Thirdly, with optimised time points, cell type-specific EVs will be isolated from the blood of patients after migraine with aura onset and characterised. In doing so, I will (1) identify previously unknown biomarkers to deepen our understanding of migraine with aura, with possible treatment derivations; (2) create a tool for researchers to investigate other neurological conditions through analysing cell type-specific BDEVs; (3) develop my skillset, publication record, visibility and networks to advance my career.